Is Bristol-Myers Squibb Company (BMY) Among the 15 Cash-Rich Dividend Stocks to Invest in Right Now [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Is Bristol-Myers Squibb Company (BMY) Among the 15 Cash-Rich Dividend Stocks to Invest in Right Now On April 9, BofA analyst Jason Gerberry lowered the price recommendation on Bristol-Myers Squibb Company (NYSE:BMY) to $67 from $68. It reiterated a Buy rating on the shares. The firm made several adjustments alongside its Q1 preview for large-cap pharma and small- to mid-cap biopharma coverage. During the Q4 2025 earnings call, management said it expects 2026 revenue to come in between $46 billion and $47.5 billion. The company pointed to steady performance in its growth portfolio, while also noting that a 12% to 16% decline in the legacy portfolio is likely as exclusivity losses continue to weigh on results. The company also expects Eliquis to grow by 10% to 15% in 2026. Adjusted diluted EPS is projected in the range of $6.05 to $6.35. CFO David Elkins said gross margins are expected to be between 69% and 70%. He also noted that total operating expenses should decline from 2025
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol-Myers Squibb: The Market Is Not Pricing The Growth Portfolio That Replaces The Patent Cliff [Seeking Alpha]Seeking Alpha
- The innovators working to make in vivo cell therapy a reality [Yahoo! Finance]Yahoo! Finance
- ??????2035????549???????? ??????????????????????? CAGR22.66% : ???????????????????? [CNET News]CNET News
- Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers [Yahoo! Finance]Yahoo! Finance
- Is It Too Late To Reassess Bristol Myers Squibb (BMY) After Its Recent Share Price Rebound [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 4/17/26 - Form DEFA14A
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- BMY's page on the SEC website